The Episodic Ataxia Gene Panel by NGS analyzes key genes associated with episodic ataxia, a neurological condition characterized by recurrent episodes of imbalance and coordination difficulties. Using an EDTA blood sample, this test identifies variants affecting ion channels and neuronal signaling pathways. Metropolis Healthcare uses advanced next-generation sequencing to ensure high accuracy and clinically relevant detection of disease-causing mutations. The results support accurate diagnosis, subtype identification, and personalized treatment planning.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0194
Frequently Asked Questions (FAQ's):
What does the Episodic Ataxia Gene Panel include at Metropolis Healthcare?
It examines multiple genes linked to different types of episodic ataxia using high-precision next-generation sequencing.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from EDTA blood and sequences the targeted genes using advanced NGS technology for accurate variant detection.
Who should consider taking this test at Metropolis Healthcare?
Individuals with recurrent episodes of dizziness, imbalance, coordination loss, or a family history of episodic ataxia may benefit from this analysis.
What sample is required for this test at Metropolis Healthcare?
A standard EDTA blood sample is needed for reliable genetic sequencing.
How long does Metropolis Healthcare take to provide the results?
Turnaround time varies based on sequencing and analysis steps, with reports delivered promptly after comprehensive evaluation.
Why choose Metropolis Healthcare for this genetic panel?
Metropolis Healthcare offers extensive gene coverage, stringent quality control, and clinically focused reporting.
Does Metropolis Healthcare offer post-test guidance?
Yes, results include expert genetic insights to help clinicians interpret findings and plan further management.
Is this test suitable for children at Metropolis Healthcare?
Yes, the panel is suitable for both pediatric and adult patients when episodic ataxia is suspected.